Moneta Group Investment Advisors’s Moderna MRNA Stock Holding History

Moneta Group Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,616	Closed	-$311K	–	661
2024 Q2	$311K	Buy	2,616 +14	+0.5%	+$1.77K	0.01%	474
2024 Q1	$277K	Buy	+2,602	New	+$262K	﹤0.01%	509
2023 Q4	–	Sell	-2,710	Closed	-$280K	–	573
2023 Q3	$280K	Buy	2,710 +84	+3%	+$9.37K	0.01%	420
2023 Q2	$319K	Sell	2,626 -266	-9%	-$35.5K	0.01%	419
2023 Q1	$444K	Buy	+2,892	New	+$477K	0.01%	337
2022 Q2	–	Sell	-7,332	Closed	-$1.26M	–	488
2022 Q1	$1.26M	Buy	7,332 +139	+2%	+$23.4K	0.05%	175
2021 Q4	$1.83M	Buy	7,193 +94	+1%	+$27.5K	0.07%	141
2021 Q3	$2.73M	Sell	7,099 -5,813	-45%	-$2.14M	0.13%	107
2021 Q2	$3.03M	Buy	12,912 +510	+4%	+$91.1K	0.14%	109
2021 Q1	$1.62M	Buy	+12,402	New	+$1.8M	0.09%	140

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moneta Group Investment Advisors's MRNA Position: Q3 2024 in Review

Moneta Group Investment Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,616 shares — an estimated $311K sold.

Moneta Group Investment Advisors first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $3.03M in Q2 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

Moneta Group Investment Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
Moneta Group Investment Advisors sold 2,616 Moderna shares in Q3 2024, an estimated $311K.
Moneta Group Investment Advisors first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
Moneta Group Investment Advisors's Moderna position peaked at $3.03M in Q2 2021.
788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Moneta Group Investment Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.